HB 17-1351

House Bill 17-1351, which has been signed into law, requires Colorado's Department of Health Care Policy and Financing, along with the Office of Behavioral Health, to create a report on residential and inpatient treatment options for substance use disorders under Medicaid. The report will cover costs, impacts on other state programs, and recommendations for better coordination among agencies. Additionally, the bill allows the health department to access data from the prescription drug monitoring program to identify individuals at risk of opioid overdose or needing more coordinated care. This bill aims to improve treatment options and support for those dealing with substance use disorders in Colorado.

Official Summary

The bill requires the department of health care policy and financing, with assistance from the department of human services' office of behavioral health, to prepare a written report for committees of the general assembly relating to residential and inpatient substance use disorder treatment options under the medicaid program, the cost of treatment, and the potential impact on other state and county programs and services if residential and inpatient substance use disorder treatment options were effective. The departments' report shall also include recommendations relating to the implementation of residential and inpatient substance use disorder treatment, better coordination of substance use disorder services among state agencies, and necessary changes to state law to implement treatment. The bill authorizes the department of health care policy and financing to access the prescription drug use monitoring program data to identify clients who may be at-risk of opioid overdose or who may benefit from increased care coordination. The bill makes an appropriation. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Votes